Correlation Between Cellectis and BetterLife Pharma
Can any of the company-specific risk be diversified away by investing in both Cellectis and BetterLife Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellectis and BetterLife Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cellectis SA and BetterLife Pharma, you can compare the effects of market volatilities on Cellectis and BetterLife Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellectis with a short position of BetterLife Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellectis and BetterLife Pharma.
Diversification Opportunities for Cellectis and BetterLife Pharma
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cellectis and BetterLife is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Cellectis SA and BetterLife Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BetterLife Pharma and Cellectis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellectis SA are associated (or correlated) with BetterLife Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BetterLife Pharma has no effect on the direction of Cellectis i.e., Cellectis and BetterLife Pharma go up and down completely randomly.
Pair Corralation between Cellectis and BetterLife Pharma
If you would invest 7.60 in BetterLife Pharma on November 4, 2024 and sell it today you would earn a total of 1.30 from holding BetterLife Pharma or generate 17.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cellectis SA vs. BetterLife Pharma
Performance |
| Timeline |
| Cellectis SA |
| BetterLife Pharma |
Cellectis and BetterLife Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cellectis and BetterLife Pharma
The main advantage of trading using opposite Cellectis and BetterLife Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellectis position performs unexpectedly, BetterLife Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BetterLife Pharma will offset losses from the drop in BetterLife Pharma's long position.| Cellectis vs. Covalon Technologies | Cellectis vs. biOasis Technologies | Cellectis vs. Mosaic Immunoengineering | Cellectis vs. Biotron Limited |
| BetterLife Pharma vs. Biotron Limited | BetterLife Pharma vs. biOasis Technologies | BetterLife Pharma vs. Covalon Technologies | BetterLife Pharma vs. Mosaic Immunoengineering |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |